Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:PFE
Pfizer
|
25.91 | 19,94% | 53,51% | 146.716,44 | 6,5% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
87.45 | 21,45% | 40,87% | 109.186,37 | 4,35% | 8,33% |
|
TSE:4568
Daiichi Sankyo Company
|
4561.00 | 0% | 0% | 8.745.499,44 | 1,3% | 0% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4095.00 | 0% | 0% | 6.424.743,58 | 4,53% | 0% |
|
NasdaqGS:MRNA
Moderna
|
103.86 | -.113,71% | -.109,46% | 39.765,88 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
196.80 | -0,68% | 16,94% | 28.607,01 | 0% | -10,89% |
|
NYSE:BAX
Baxter International Inc
|
40.04 | 60,82% | 85,13% | 20.394,25 | 2,88% | -3,14% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
147.70 | 0% | 0% | 18.676,98 | 0% | 0% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
91.51 | 114,46% | 184,78% | 17.366,31 | 0% | 32,46% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
41.55 | -.150,35% | -.143,74% | 6.374,47 | 0% | 0% |
|
TSE:4516
Nippon Shinyaku
|
4280.00 | 0% | 0% | 329.220,38 | 2,86% | 0% |
|
NasdaqGS:DYN
Dyne Therapeutics
|
25.44 | 0% | 0% | 2.062 | 0% | 0% |
|
NasdaqGS:DCPH
Deciphera Pharmaceuticals
|
14.90 | 0% | 0% | 1.286,34 | 0% | 0% |
|
NasdaqGM:WVE
Wave Life Sciences
|
5.74 | 0% | 0% | 768,25 | 0% | 0% |
|
NasdaqGM:FULC
Fulcrum Therapeutics
|
7.36 | 0% | 0% | 680,67 | 0% | 0% |
|
NasdaqGS:ABUS
Arbutus Biopharma
|
2.97 | 0% | 0% | 474,02 | 0% | 0% |
|
NasdaqGS:STOK
Stoke Therapeutics
|
12.21 | 0% | 0% | 318,38 | 0% | 0% |
|
ASX:PYC
PYC Therapeutics
|
0.10 | 0% | 0% | 294,9 | 0% | 0% |
|
NYSEAM:AIM
AIM ImmunoTech
|
0.48 | 0% | 0% | 19,05 | 0% | 0% |
